Susan Dorman is an Infectious Disease physician affiliated with Medical University of South Carolina. OpenAlex indexes 214 publications with 13,272 citations (h-index 58); ClinicalTrials.gov lists 8 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
171 Ashley Ave
Charleston, SC 294250005
Telephone
843-792-1414Registry record last updated 21 Jul 2022.
Clinical trials
- A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Sponsor: Centers for Disease Control and Prevention
- Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa
Sponsor: Tuberculosis Clinical Diagnostics Research Consortium
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BioNTech SEProgram year20241 payment
- Insmed, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
85.8%Macrolide Antimicrobial26.1%Azithromycin100%Part D≥28 patientsAntimycobacterial18.7%Ethambutol Hcl100%Part D≥17 patients+ 4 more classes in this area
Nervous system
7.6%Other antidepressants7.6%Mirtazapine100%Part D<11 patientsMetabolism & gastrointestinal
3.4%Serotonin-3 Receptor Antagonist3.4%Ondansetron Odt100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- CTSA K12 Program at the Medical University of South Carolina
Medical University of South Carolina
FY2026$756,000K12TR005297 - Novel strategies for treatment of Mycobacterium abscessus pulmonary disease
Medical University of South Carolina
FY2025$240,878R34AI186857 - Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis
Medical University of South Carolina
FY2020$556,523R01AI129411
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
New England Journal of Medicine
2021 - Duration of Exposure Among Close Contacts of Patients With Infectious Tuberculosis and Risk of Latent Tuberculosis Infection
Clinical Infectious Diseases
2020 - Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis
The Journal of Infectious Diseases
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Tanya Turan, MD
Medical University of South Carolina
Michael Zile, MD
Medical University of South Carolina
Don Rockey, MD
Medical University of South Carolina
William Creasman, MD
Medical University of South Carolina
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”